Axicabtagene ciloleucel,Cyclophosphamide,Fludarabine
Gilead
['lymphoma']
jason westin, md, fascp, director, lymphoma clinical research program at university of texas , discussed the implications of overall survival data that he presented at #asco23. watch it now: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.